Coronary disease & ACS

Diagnostic accuracy and prognostic value of cardiovascular magnetic resonance (CMR) in patients with suspected acute coronary syndrome: a meta-analysis

Eur Heart J Cardiovasc ImagingPublished meta-analysis

Authors' conclusion

CMR can detect obstructive CAD and diagnose NSTE-ACS with excellent pooled sensitivity and specificity. CMR findings are strongly associated with clinical outcome in patients with suspected NSTE-ACS.

Study context

Population
Patients with suspected non-ST-elevation acute coronary syndrome (NSTE-ACS)
Participants
1,386 patients16 studies
Comparison
Diagnostic accuracy of CMR to detect obstructive coronary artery disease (CAD) and NSTE-ACS, and the prognostic value of CMR in patients with suspected NSTE-ACS
Outcome
Detection of obstructive CAD (eight studies)
Methodological detailsbivariate random-effects model, pre-registered in PROSPERO
  • Bivariate random-effects model
  • Pre-registered in PROSPERO

Pooled result

As reported in the abstract

GroupPooled sensitivityPooled specificityPooled LR+Pooled LR-
CMR85% (95%CI 78-91%)73% (95%CI 57-85%)3.20 (95%CI 1.78-5.73)0.20 (95%CI 0.11-0.36)

CMR

Pooled sensitivity85% (95%CI 78-91%)
Pooled specificity73% (95%CI 57-85%)
Pooled LR+3.20 (95%CI 1.78-5.73)
Pooled LR-0.20 (95%CI 0.11-0.36)

Further pooled results

OutcomeCMR
Diagnosis of NSTE-ACS (five studies)
Pooled sensitivity83% (95%CI 73-89%)
Pooled specificity89% (95%CI 72-96%)
Pooled LR+7.45 (95%CI 2.77-20.02)
Pooled LR-0.20 (95%CI 0.13-0.30)
Prognosis based on ACS-related outcomes (four studies)
Pooled sensitivity98% (95%CI 42-100%)
Pooled specificity85% (95%CI 65-95)
Pooled LR+6.55 (95%CI 2.45-17.54)
Pooled LR-0.03 (95%CI 0-1.54)

Original publication

Diagnostic accuracy and prognostic value of CMR in patients with suspected acute coronary syndrome: a meta-analysis. Eur Heart J Cardiovasc Imaging. Published 16 December 2025. doi:10.1093/ehjci/jeaf356

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.